Premium
Leprosy in a renal transplant recipient: review of the literature
Author(s) -
Guditi S.,
Ram R.,
Ismal K.M.,
Sahay M.,
Dakshinamurthy K.V.,
Girish N.,
Prasad N.
Publication year - 2009
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/j.1399-3062.2009.00428.x
Subject(s) - medicine , dapsone , clofazimine , prednisolone , immunosuppression , skin biopsy , thalidomide , transplantation , azathioprine , leprosy , dermatology , rifampicin , surgery , tacrolimus , biopsy , tuberculosis , pathology , multiple myeloma , disease
A 52‐year‐old male underwent living‐related renal transplantation. He received prednisolone, azathioprine, and cyclosporine as immunosuppression protocol. Eleven years after transplantation, he developed pyrexia with multiple nodular lesions on his limbs, trunk, and face. Skin biopsy and smears showed the presence of numerous acid‐fast bacilli with 5% sulfuric acid indicative of Mycobacterium leprae . He was initiated on multidrug therapy (MDT) including dapsone, clofazimine, and rifampicin. After 2 years of MDT, he developed new multiple erythematous, tender subcutaneous nodules in crops over his face and upper limbs. Skin biopsies and histopathological examination confirmed the diagnosis of type 2 lepra reaction or erythema nodosa leprosum. He was managed with an increase in the dose of prednisolone and thalidomide. He was continued on MDT.